Answers are grounded in this paper and cite their sources.
Background: Uterine leiomyomas are common and clinically significant, burdening healthcare systems. Leptin, a hormone produced by the obese (Ob) gene, is mostly synthesised in adipose tissue and expressed in several organs, including myomas and the myometrium. The primary goal of this study was to examine blood leptin levels in women with and without uterine leiomyomas. Method: This prospective case-control research included 50 reproductive-age women. The research group had 25 women with uterine leiomyomas, while the control group had 25 healthy women without, as determined by ultrasonography. BMI was calculated for all subjects. Haemoglobin, BUN, serum creatinine, fasting blood sugar, and serum leptin were tested. Women with and without myomas were compared for serum leptin levels using radioimmunoassay. Results: The average blood leptin levels in women with uterine myomas (7.57± 2.88 ng/mL) were significantly lower (p=0.0001) than in normal women (9.56± 1.77 ng/mL). Furthermore, women with myomas had substantially lower blood leptin levels to body mass index (0.267±0.09) (p=0.0001) compared to normal women (0.34±0.05). In both groups, blood leptin levels were positively correlated with body mass index (r=0.587, p=0.0001) in women with myomas and those without (r=0.608, p=0.0001). Conclusion: the diminished serum leptin levels observed in women with uterine myomas, regardless of their body mass index, suggest a lack of significant up-regulation of leptin production in response to increased adiposity.
No takes yet. Share an insight, caveat, or question.
Alfartosy et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: